Clarity Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44M Buy
36,647
+2,021
+6% +$2.06M 3.73% 9
2026
Q1
$31.8M Buy
34,626
+755
+2% +$765K 3.46% 8
2025
Q4
$36.4M Sell
33,871
-3,803
-10% -$3.64M 3.37% 7
2025
Q3
$28.7M Buy
37,674
+969
+3% +$721K 2.85% 11
2025
Q2
$28.6M Buy
36,705
+7,945
+28% +$6.17M 3.08% 11
2025
Q1
$23.8M Sell
28,760
-3,732
-11% -$3.11M 2.73% 13
2024
Q4
$25.1M Buy
32,492
+15,206
+88% +$12.6M 3% 12
2024
Q3
$15.3M Sell
17,286
-898
-5% -$807K 1.78% 18
2024
Q2
$16.5M Buy
18,184
+5,843
+47% +$4.67M 2.43% 16
2024
Q1
$9.6M Buy
12,341
+11,716
+1,875% +$8.34M 1.45% 28
2023
Q4
$364K Sell
625
-71
-10% -$41.4K 0.06% 78
2023
Q3
$374K Buy
696
+26
+4% +$13.4K 0.06% 77
2023
Q2
$314K Buy
+670
New +$281K 0.04% 85

Other funds holding LLY

Clarity Financial's LLY Position: Q2 2026 in Review

Clarity Financial increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $2.06M and bringing the position to 36,647 shares worth $44M. The position accounts for 3.73% of the portfolio, ranked #9.

Clarity Financial first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,827 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clarity Financial held 36,647 shares of Eli Lilly worth $44M as of Q2 2026.
  • Clarity Financial bought 2,021 Eli Lilly shares in Q2 2026, an estimated $2.06M.
  • Eli Lilly made up 3.73% of Clarity Financial's portfolio in Q2 2026, its #9 holding.
  • Clarity Financial first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 2,827 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clarity Financial's 13F filing for Q2 2026, filed 20 Jul 2026.